𝛽-Thalassemia: HiJAKing Ineffective Erythropoiesis and Iron Overload
𝛽-thalassemia encompasses a group of monogenic diseases that have in common defective synthesis of 𝛽-globin. The defects involved are extremely heterogeneous and give rise to a large phenotypic spectrum, with patients that are almost asymptomatic to cases in which regular blood transfusions are requ...
Saved in:
| Main Authors: | , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2010-01-01
|
| Series: | Advances in Hematology |
| Online Access: | http://dx.doi.org/10.1155/2010/938640 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1832565968235134976 |
|---|---|
| author | Luca Melchiori Sara Gardenghi Stefano Rivella |
| author_facet | Luca Melchiori Sara Gardenghi Stefano Rivella |
| author_sort | Luca Melchiori |
| collection | DOAJ |
| description | 𝛽-thalassemia encompasses a group of monogenic diseases that have in common defective synthesis of 𝛽-globin. The defects involved are extremely heterogeneous and give rise to a large phenotypic spectrum, with patients that are almost asymptomatic to cases in which regular blood transfusions are required to sustain life. As a result of the inefficient synthesis of 𝛽-globin, the patients suffer from chronic anemia due to a process called ineffective erythropoiesis (IE). The sequelae of IE lead to extramedullary hematopoiesis (EMH) with massive splenomegaly and dramatic iron overload, which in turn is responsible for many of the secondary pathologies observed in thalassemic patients. The processes are intimately linked such that an ideal therapeutic approach should address all of the complications. Although 𝛽-thalassemia is one of the first monogenic diseases to be described and represents a global health problem, only recently has the scientific community started to focus on the real molecular mechanisms that underlie this disease, opening new and exciting therapeutic perspectives for thalassemic patients worldwide. |
| format | Article |
| id | doaj-art-f9481ffd8afa454da15e92633a461f9a |
| institution | Kabale University |
| issn | 1687-9104 1687-9112 |
| language | English |
| publishDate | 2010-01-01 |
| publisher | Wiley |
| record_format | Article |
| series | Advances in Hematology |
| spelling | doaj-art-f9481ffd8afa454da15e92633a461f9a2025-02-03T01:06:14ZengWileyAdvances in Hematology1687-91041687-91122010-01-01201010.1155/2010/938640938640𝛽-Thalassemia: HiJAKing Ineffective Erythropoiesis and Iron OverloadLuca Melchiori0Sara Gardenghi1Stefano Rivella2Weill Cornell Medical College, Department of Pediatrics, Division of Hematology-Oncology, 515E 71st street, S702, New York, NY 10021, USAWeill Cornell Medical College, Department of Pediatrics, Division of Hematology-Oncology, 515E 71st street, S702, New York, NY 10021, USAWeill Cornell Medical College, Department of Pediatrics, Division of Hematology-Oncology, 515E 71st street, S702, New York, NY 10021, USA𝛽-thalassemia encompasses a group of monogenic diseases that have in common defective synthesis of 𝛽-globin. The defects involved are extremely heterogeneous and give rise to a large phenotypic spectrum, with patients that are almost asymptomatic to cases in which regular blood transfusions are required to sustain life. As a result of the inefficient synthesis of 𝛽-globin, the patients suffer from chronic anemia due to a process called ineffective erythropoiesis (IE). The sequelae of IE lead to extramedullary hematopoiesis (EMH) with massive splenomegaly and dramatic iron overload, which in turn is responsible for many of the secondary pathologies observed in thalassemic patients. The processes are intimately linked such that an ideal therapeutic approach should address all of the complications. Although 𝛽-thalassemia is one of the first monogenic diseases to be described and represents a global health problem, only recently has the scientific community started to focus on the real molecular mechanisms that underlie this disease, opening new and exciting therapeutic perspectives for thalassemic patients worldwide.http://dx.doi.org/10.1155/2010/938640 |
| spellingShingle | Luca Melchiori Sara Gardenghi Stefano Rivella 𝛽-Thalassemia: HiJAKing Ineffective Erythropoiesis and Iron Overload Advances in Hematology |
| title | 𝛽-Thalassemia: HiJAKing Ineffective Erythropoiesis and Iron Overload |
| title_full | 𝛽-Thalassemia: HiJAKing Ineffective Erythropoiesis and Iron Overload |
| title_fullStr | 𝛽-Thalassemia: HiJAKing Ineffective Erythropoiesis and Iron Overload |
| title_full_unstemmed | 𝛽-Thalassemia: HiJAKing Ineffective Erythropoiesis and Iron Overload |
| title_short | 𝛽-Thalassemia: HiJAKing Ineffective Erythropoiesis and Iron Overload |
| title_sort | 𝛽 thalassemia hijaking ineffective erythropoiesis and iron overload |
| url | http://dx.doi.org/10.1155/2010/938640 |
| work_keys_str_mv | AT lucamelchiori βthalassemiahijakingineffectiveerythropoiesisandironoverload AT saragardenghi βthalassemiahijakingineffectiveerythropoiesisandironoverload AT stefanorivella βthalassemiahijakingineffectiveerythropoiesisandironoverload |